BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 29207076)

  • 1. Antiangiogenic effects of catalpol on rat corneal neovascularization.
    Han Y; Shen M; Tang LY; Tan G; Yang QC; Ye L; Ye LH; Jiang N; Gao GP; Shao Y
    Mol Med Rep; 2018 Feb; 17(2):2187-2194. PubMed ID: 29207076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acidic/neutral amino acid residues substitution in NH2 terminal of plasminogen kringle 5 exerts enhanced effects on corneal neovascularization.
    Li C; Li L; Cheng R; Dai Z; Li C; Yao Y; Zhou T; Yang Z; Gao G; Yang X
    Cornea; 2013 May; 32(5):680-8. PubMed ID: 23343948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of pirfenidone in alkali burn rat cornea.
    Jiang N; Ma M; Li Y; Su T; Zhou XZ; Ye L; Yuan Q; Zhu P; Min Y; Shi W; Xu X; Lv J; Shao Y
    Int Immunopharmacol; 2018 Nov; 64():78-85. PubMed ID: 30153530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xanthatin inhibits corneal neovascularization by inhibiting the VEGFR2‑mediated STAT3/PI3K/Akt signaling pathway.
    Shen M; Zhou XZ; Ye L; Yuan Q; Shi C; Zhu PW; Jiang N; Ma MY; Yang QC; Shao Y
    Int J Mol Med; 2018 Aug; 42(2):769-778. PubMed ID: 29717775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiangiogenesis effects of endostatin in retinal neovascularization.
    Bai YJ; Huang LZ; Zhou AY; Zhao M; Yu WZ; Li XX
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):619-26. PubMed ID: 23545016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nornicotine and Nicotine Induced Neovascularization via Increased VEGF/PEDF Ratio.
    Zhang Y; Ma A; Wang L; Zhao B
    Ophthalmic Res; 2015; 55(1):1-9. PubMed ID: 26536586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of HUVEC tube formation via suppression of NFκB suggests an anti-angiogenic role for SLURP1 in the transparent cornea.
    Swamynathan S; Loughner CL; Swamynathan SK
    Exp Eye Res; 2017 Nov; 164():118-128. PubMed ID: 28803936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celastrol nanomicelles attenuate cytokine secretion in macrophages and inhibit macrophage-induced corneal neovascularization in rats.
    Li Z; Li J; Zhu L; Zhang Y; Zhang J; Yao L; Liang D; Wang L
    Int J Nanomedicine; 2016; 11():6135-6148. PubMed ID: 27920521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emodin suppresses alkali burn-induced corneal inflammation and neovascularization by the vascular endothelial growth factor receptor 2 signaling pathway.
    Xueying Z; Liang G; Siyi L; Fengyue LI; Mingli L; Wanting L; Chun M; Guanghui L
    J Tradit Chin Med; 2024 Apr; 44(2):268-276. PubMed ID: 38504533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyethylene glycol-modified pigment epithelial-derived factor: new prospects for treatment of retinal neovascularization.
    Bai YJ; Huang LZ; Xu XL; Du W; Zhou AY; Yu WZ; Li XX
    J Pharmacol Exp Ther; 2012 Jul; 342(1):131-9. PubMed ID: 22495066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of curcumin on corneal neovascularization in vitro and in vivo.
    Bian F; Zhang MC; Zhu Y
    Ophthalmologica; 2008; 222(3):178-86. PubMed ID: 18497527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo and in vitro inhibitory effect of amniotic extraction on neovascularization.
    Jiang A; Li C; Gao Y; Zhang M; Hu J; Kuang W; Hao S; Yang W; Xu C; Gao G; Wang Z; Liu Z
    Cornea; 2006 Dec; 25(10 Suppl 1):S36-40. PubMed ID: 17001191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization.
    Zhang Z; Ma JX; Gao G; Li C; Luo L; Zhang M; Yang W; Jiang A; Kuang W; Xu L; Chen J; Liu Z
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4062-71. PubMed ID: 16249481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of corneal neovascularization with the combination of bevacizumab and plasmid pigment epithelium-derived factor-synthetic amphiphile INTeraction-18 (p-PEDF-SAINT-18) vector in a rat corneal experimental angiogenesis model.
    Kuo CN; Chen CY; Chen SN; Yang LC; Lai LJ; Lai CH; Chen MF; Hung CH; Chen CH
    Int J Mol Sci; 2013 Apr; 14(4):8291-305. PubMed ID: 23591843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical administration of peroxiredoxin-6 on the cornea suppresses inflammation and neovascularization induced by ultraviolet radiation.
    Shi H; Yu HJ; Wang HY; Wang WT; Jin SH; Zhu P; Li SJ; Rong CT; Li JY
    Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8016-28. PubMed ID: 23139277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of topical netrin-4 inhibits corneal neovascularization in alkali-burn rats.
    Han Y; Shao Y; Liu T; Qu YL; Li W; Liu Z
    PLoS One; 2015; 10(4):e0122951. PubMed ID: 25853509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-targeted and localized AAV5-DCN and AAV5-PEDF combination gene therapy abrogates corneal fibrosis and concurrent neovascularization in rabbit eyes in vivo.
    Mohan RR; Gupta S; Kumar R; Sinha NR; Landreneau J; Sinha PR; Tandon A; Chaurasia SS; Hesemann NP
    Ocul Surf; 2024 Apr; 32():13-25. PubMed ID: 38191093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Netrin-1 simultaneously suppresses corneal inflammation and neovascularization.
    Han Y; Shao Y; Lin Z; Qu YL; Wang H; Zhou Y; Chen W; Chen Y; Chen WL; Hu FR; Li W; Liu Z
    Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1285-95. PubMed ID: 22323486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Peptide NT/K-CFY Derived from Kringle Structure of Neurotrypsin Inhibits Neovascularization.
    Yao X; Chen C; Zhang J; Xu Y; Xiong S; Gu Q; Xu X; Suo Y
    Curr Eye Res; 2021 Oct; 46(10):1551-1558. PubMed ID: 33870816
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibitory effect of rapamycin on corneal neovascularization in vitro and in vivo.
    Kwon YS; Hong HS; Kim JC; Shin JS; Son Y
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):454-60. PubMed ID: 15671269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.